Stephen Thaler’s next DABUS hearing at the UK High Court puts the inventorship test on trial. Thaler's counsel Ryan Abbott ...

Far from a wave of refusals, the major trademark decision was followed by pragmatic and reassuring advice from the IP office, says Jade MacIntyre of Lewis Silkin. If you don't have a login or your ...

This LSPN session features experts from EIP, The Broad Institute of MIT and Harvard, Pfizer, and an independent specialist ...

18 July 2025 The lawyer behind a landmark ruling that reshaped prior art rules reveals how the decision will impact patent-opposition proceedings, influence trade secrets, and why strong legal ...

Neil Campbell was instrumental in the G1/23 decision overturning a 30-year European patent precedent.

Bad actors use AI to artificially inflate GitHub repository credibility, says CITMA report | AI-generated counterfeits ...

Three of the new shareholders have IP and life sciences expertise, bringing a commercial and policy focus to the firm. If you ...

LSPN experts from Goodwin Law, Invivyd, and New England Biolabs discuss the challenges of patent eligibility under 35 U.S.C. § 101 in life sciences innovation. The session explores strategies to ...

After almost 30 years as head of IP at Bayer, Jörg Thomaier is to retire and is handing the baton to Dorian Immler. Speaking ...